Kengo Isshiki
CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
NeuroDerm
Former names:
Drug-device Combination Solutions for Central Nervous System Disorders
Stealth Mode
by Mitsubishi Tanabe Pharma Corporation on Jul, 2017
NeuroDerm
NeuroDerm Overview
NeuroDerm specializes in integrating proprietary pharmaceutical formulations, state-of-the-art delivery system, and digital health solutions with the aim of reducing disease burden and improving the quality of life of patients and their families.
NeuroDerm’s flagship product ND0612 is currently in late stage development for Parkinson’s disease patients experiencing motor fluctuations. Its system for self-administered continuous subcutaneous infusion of the gold standard levodopa/carbidopa, was designed specifically to be a user-friendly system for people with Parkinson's disease, to maintain steady therapeutic levodopa plasma concentrations for the purpose of improving fluctuations, that is, reducing patients’ "OFF" time without increasing troublesome dyskinesia.
Its tailored solution potentially offers sustained relief (compared to oral immediate-release levodopa/carbidopa treatments) and empowers patients and their families to regain control of their lives with greater daily-life predictability and independence.
NeuroDerm’s flagship product ND0612 is currently in late stage development for Parkinson’s disease patients experiencing motor fluctuations. Its system for self-administered continuous subcutaneous infusion of the gold standard levodopa/carbidopa, was designed specifically to be a user-friendly system for people with Parkinson's disease, to maintain steady therapeutic levodopa plasma concentrations for the purpose of improving fluctuations, that is, reducing patients’ "OFF" time without increasing troublesome dyskinesia.
Its tailored solution potentially offers sustained relief (compared to oral immediate-release levodopa/carbidopa treatments) and empowers patients and their families to regain control of their lives with greater daily-life predictability and independence.
Cumulative Funding Raised Over Time ($)
Employees Over Time
NeuroDerm Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Jan 9, 2023
www.prnewswire.com
NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations
#Customers
Aug 28, 2019
www.prnewswire.com
Phase 3 Clinical Trial Evaluating Continuous Subcutaneous Carbidopa/Levodopa (ND0612) Initiated In The United States For Parkinson's Disease With Motor Fluctuations
#Customers
Jul 24, 2017
globenewswire.com
NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in Cash
#Acquisition
Jun 13, 2017
www.globes.co.il
Neuroderm mulls several acquisition offers
#Acquisition
Mar 2, 2017
www.globes.co.il
Neuroderm jumps on successful trial results
#Customers
Companies you might be interested in
Driven by Finder AI
-
Rafa LaboratoriesPrescription and Over-the-Counter Medicines51-200 employees • Funding Stage: Acquired
shared sectors
Are these companies similar? -
NurExone BiologicEV-based Drug Platform to Treat Damage in the Central Nerve System11-50 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
KI
UD
AN
NH
Contact Team
Affiliated Organizations
(null)Web & social links
https://neuroderm.com
Locations
Israel
Prof. Haim Pekeris 3, Rehovot, Israel
Offices Abroad
Photos & videos
(1)No Data, yet.
Sorry, no content found under this section.
NeuroDerm Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)NeuroDerm Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Delisting
Oct 2017
Stock Exchange
NASDAQ
M&A
$1.1B
Jul 2017
Type
Acquisition
Was acquired by
Mitsubishi Tanabe Pharma Corporation
$1.1B
Initial Public Offering
EXIT
$45M
Nov 2014
Stock Exchange
NASDAQ
Valuation
$164M
$45M
Private Equity Funding
Non-Equity Funding
Mergers and Acquisitions
NeuroDerm Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Delisting
Oct 2017
Stock Exchange
NASDAQ
M&A
$1.1B
Jul 2017
Type
Acquisition
Was acquired by
Mitsubishi Tanabe Pharma Corporation
$1.1B
Initial Public Offering
EXIT
$45M
Nov 2014
Stock Exchange
NASDAQ
Valuation
$164M
$45M
NeuroDerm News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Jan 9, 2023
www.prnewswire.com
NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations
#Customers
Aug 28, 2019
www.prnewswire.com
Phase 3 Clinical Trial Evaluating Continuous Subcutaneous Carbidopa/Levodopa (ND0612) Initiated In The United States For Parkinson's Disease With Motor Fluctuations
#Customers
Jul 24, 2017
globenewswire.com
NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in Cash
#Acquisition
Jun 13, 2017
www.globes.co.il
Neuroderm mulls several acquisition offers
#Acquisition
Mar 2, 2017
www.globes.co.il
Neuroderm jumps on successful trial results
#Customers
Related Content
NeuroDerm Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
Rafa LaboratoriesPrescription and Over-the-Counter Medicines51-200 employees • Funding Stage: Acquired
shared sectors
Are these companies similar?
-
NurExone BiologicEV-based Drug Platform to Treat Damage in the Central Nerve System11-50 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
NeuroDerm Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,